40 peer-reviewed studies · Evidence score: 8.5/10
Zhou P et al. • PloS one (2024)
The rankings of safety and efficacy of the 12 antioxidants vary.
Zhu R et al. • Thrombosis research (2022)
These data show a high rate of aPS/PT positivity in patients with APS (especially in those positive for LAC) but further studies are needed to ascertain whether this test might be useful in the laboratory classification criteria of APS.
Sciascia S et al. • Thrombosis and haemostasis (2014)
Their inclusion as laboratory criteria for the APS should be indisputably further explored.
Nogueira-de-Almeida CA et al. • Central nervous system agents in medicinal chemistry (2023)
The areas of neurology and psychiatry have shown great advances regarding the deepening of knowledge in prophylaxis and pathophysiology, as well as in the treatment of established diseases.
Takanashi Y et al. • Lipids in health and disease (2024)
This systematic-review examined the effects of Phosphatidylserine.
Glade MJ, Smith K • Nutrition (2015)
Phosphatidylserine supplementation supports cognitive functions that decline with age.
Jin E et al. • Vascular pharmacology (2025)
The prevalence of aPL in COVID-19 patients was significantly higher than in the healthy control group.
Papadimitriou E et al. • PloS one (2022)
The prevalence of antiphospholipid antibodies, particularly that of anti-beta2 glycoprotein-I and anti-phosphatidylserine antibodies, in women experiencing at least two implantation failures in IVF-ET without diagnosis of antiphospholipid syndrome is significantly greater than either in women who had a successful implantation after IVF-ET or women with at least one successful spontaneous pregnancy or unselected healthy fertile women with no history of IVF-ET.
Bruton A et al. • Journal of alternative and complementary medicine (New York, N.Y.) (2021)
Conclusions: Preliminary evidence suggests that phosphatidylserine may be effective for reducing symptoms of inattention in children with ADHD, although the quality of the evidence is low and additional research in this area is warranted.
Yang Z et al. • European journal of medical research (2022)
This study provides a systematic review of metabolomics of ICP and deepens our understanding of the etiology of ICP.
Duan H et al. • Journal of affective disorders (2025)
This food supplement containing phosphatidylserine could improve different cognitive functions of MCI patients, especially short-term memory, and increase serum n-3 PUFAs and neurotransmitters levels.
Higgins SJ et al. • The Journal of clinical investigation (2018)
Finally, interventions targeting Tie2 may normalize coagulation in inflammatory states while averting the bleeding risks of current DIC therapies.
Tian Z et al. • Nutrients (2022)
The results suggest that WSTC can inhibit oxidative stress and its related platelet apoptosis, which may provide a basis for the primary prevention of WSTC in ASCVD.
Youngblood MW et al. • Nature communications (2025)
This rct examined the effects of Phosphatidylserine.
Hsiehchen D et al. • Nature communications (2024)
This rct examined the effects of Phosphatidylserine.
Ramberg C et al. • Journal of thrombosis and haemostasis : JTH (2022)
Rosuvastatin treatment caused a substantial decrease in plasma PPL activity, suggesting that a PPL-dependent attenuation of coagulation activation may contribute to a reduced VTE risk following statin treatment.
Qi Z et al. • Medicine and science in sports and exercise (2024)
Changes of lipidome after exercise and/or diet interventions were associated with HFC reductions, which are independent of visceral fat reduction, particularly in metabolites belonging to PC.
Rheims S et al. • Epilepsia open (2024)
Our study remaining underpowered, no formal conclusion about the effect of Ps-Omega3 could be drawn.
D'Orio M et al. • Acta bio-medica : Atenei Parmensis (2023)
Dietary integration could be considered as an option in patients who could not undergo surgery.
Jiang L et al. • Asia Pacific journal of clinical nutrition (2022)
Lactobacillus casei supplementation during the intensive phase of tuberculosis treatment can significantly modulate inflammatory cytokines and metabolites.